300 related articles for article (PubMed ID: 28157695)
1. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
Chen M; Li J; Zhuang C; Cai Z
Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
5. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
Chen Q; Fu L
PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Xie J; Chen J; Zhu H; Zeidler-Erdely PC; Yang C; Wang Z
Environ Int; 2024 Mar; 185():108494. PubMed ID: 38364571
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis.
Lei X; Li L; Duan X
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429229
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway.
Lu H; Zhu C; Chen Y; Ruan Y; Fan L; Chen Q; Wei Q
Clin Transl Oncol; 2022 Jun; 24(6):1124-1133. PubMed ID: 35098448
[TBL] [Abstract][Full Text] [Related]
13. Role of the lncRNA ABHD11-AS
Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y
Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA ABHD11-AS1 promote cells proliferation and invasion of colorectal cancer via regulating the miR-1254-WNT11 pathway.
He D; Yue Z; Liu L; Fang X; Chen L; Han H
J Cell Physiol; 2019 Jul; 234(7):12070-12079. PubMed ID: 30537177
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
[TBL] [Abstract][Full Text] [Related]
17. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.
Wang F; Zu Y; Huang W; Chen H; Xie H; Yang Y
Biochem Biophys Res Commun; 2018 Sep; 504(1):171-176. PubMed ID: 30177388
[TBL] [Abstract][Full Text] [Related]
20. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]